|Capitol Connections March 29, 2013|
March 29, 2013
IACP Sends Letter to Senate Committee on Health, Education, Labor and Pensions (HELP)
On March 20, 2013, the International Academy of Compounding Pharmacists (IACP), provided comments and insights, as requested by the Senate Health, Education, Labor and Pension Committee (HELP), into a conceptual model proposed by the Food and Drug Administration (FDA), intended to address the safety of compounded medications and to clarify the FDA's authority in this area.
Inside Health Policy Interviews IACP: "Compounders Tweak FDA's Three-Prong Test, Say Expanding Agency Authority Is 'Premature'"
IACP's Executive Vice President/CEO David G. Miller, RPh, was interviewed by Inside Health Policy's Alaina Busch regarding the Academy's letter sent last week to the Senate Committee on Health, Education, Labor and Pensions (HELP). "The International Academy of Compounding Pharmacists told the Senate health committee last week that expanding FDA's authority to a new regulatory category would be “premature” and that an agency proposal to determine which facilities would fall into this new area should be employed to draw a line between compounding and manufacturing. FDA has privately floated to lawmakers a three-prong test involving whether the product is a sterile preparation, shipped interstate and compounded prior to a prescription, according to a letter IACP sent to the committee and obtained by Inside Health Policy." Click here to read more.
Drug Compounding Bills Scheduled for Massachusetts Hearing
On the heels of a deadly fungal meningitis outbreak linked to a Framingham compounding pharmacy, lawmakers plan next week to hold a public hearing on a slate of bills aimed at further regulating the industry. The Joint Committee on Public Health announced plans for a noon hearing on April 2, 2013, in Room B-1 on bills addressing, "state oversight, licensing and safety issues at compounding pharmacies," according to committee co-chair Rep. Jeffrey Sanchez. Compounding industry legislation vaulted to the top of the to-do lists of legislative leaders last year due to the serious problems stemming from the New England Compounding Center. Among the bills scheduled for next week's hearing is one (H 39) sponsored by Gov. Deval Patrick. Dr. Lauren Smith, commissioner of the Department of Public Health, which regulates compounding pharmacies, is among those scheduled to testify, along with officials from the industry and members of the Special Commission on the Oversight of Compounding Pharmacies. IACP will keep our Members apprised on any developments.
Animal Drug User Fee Bill
Please note that the Animal Drug User Fee bill (S. 622) was scheduled for Senate floor action on March 20th, 2013. It is expected to appear on the Senate agenda at any point after their break. IACP is monitoring for any potential amendments on compounding.
Save the Date: IACP Member Town Hall, April 16th
Join IACP for a Member Town Hall on Tuesday, April 16 @ 2pm Eastern. IACP leadership will share the latest information with you - on the agenda: New Federal Legislation. A Blast Fax will be sent to all Members in the coming week. Help IACP reach out to you! Make sure we have all of your current contact information. Please email updates to firstname.lastname@example.org.
IACP Continues to Work with Media
IACP has spent the last several months engaged in a high volume of media interviews to help set the record straight about pharmacy compounding. Click here to view a list of all news coverage in which IACP has been involved from December 2012 through March 2013. Many of the links are to wire stories that the other publications on the list also covered.
Currently, IACP is finalizing dates for a Washington/New York/Boston/Nashville media tour where IACP's David Miller will meet one-on-one with major media outlet reporters “on background” to provide information and perspective on compounding and answer questions.This is one part of IACP’s strategy to ensure that our position and perspective are known by journalists covering compounding, and will be key to stories generated going forward.
IACP Foundation Research Published
The IACP Foundation is very pleased to announce that the research study funded for Kenna Stephenson's, MD, FAAFP, The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women, has been published in the International Journal of Pharmaceutical Compounding, January/February 2013 edition.
Click here to view the IJPC abstract.
The Research and Education Committee was formed in June 2004 to fulfill the IACP Foundation’s mission to advance the art and science of pharmacy compounding by funding research and public education initiatives within the profession. An 18-member volunteer committee worked diligently the first year to establish the priorities for giving and the application process. Since 2005, the IACP Foundation has awarded more than $196,000 for studies researching compounded preparation potency and stability and outcomes of treatment with compounded medications.
Deadline Extended: Join APhA's Compounding Special Interest Group!
To enroll in the American Pharmacists Association (APhA's) Compounding Special Interest Group, please click here. The extended deadline to join is Wednesday, April 3, 2013 - you will need your APhA member number when you enroll.
Alabama Pharmacy Association: 2013 Pharmacy Legislative Day
Alabama Members - Mark your calendars for April 18, 2013, in Montgomery, Ala, for the Alabama Pharmacy Association's (APA) Pharmacy Legislative Day. Legislators from all over the state will be attending, and we need every pharmacist and technician there to show that pharmacy WILL NOT be overlooked! Click here for more information. Please visit APA's website at www.aparx.org for more details or to register online.
Session Highlight: Community Pharmacy Practice with Lynnae Mahaney, Center for Pharmacy Practice Accreditation
Join your fellow compounders in Washington, D.C., this June! The 19th Annual Compounders on Capitol Hill (CCH) will be held June 1-4, 2013 at the Crystal Gateway Marriott in Arlington, Va. Located only two miles from Ronald Reagan National Airport (DCA), the Crystal Gateway Marriott offers immediate lobby access to Washington, D.C.’s world-famous Metro system and a quick ride to all the museums, sights, restaurants, and even the Capital.
Don't Miss Out on the Networking Opportunities our Dynamic Exhibit Hall has to Offer!
The IACP Exhibitor Experience is held in conjunction with Compounders on Capitol Hill (CCH). The exhibition provides pharmacy owners, technicians, and marketing representatives the opportunity to meet with 30 exhibiting companies specializing in pharmacy compounding services. Don’t miss the opportunity to see how you can work with IACP Corporate Partners and CCH exhibitors. This year’s show includes six, first-time CCH exhibiting companies. Among those new CCH exhibitors are: bioMérieux; EMD Millipore; International Medical Industries, Inc.; Live Oak Bank; Mar Cor Purification; and Torpac Capsules.
Once again, the Exhibition Hall is located directly next to the General Session room and is the location for breakfast and lunch on both Sunday, June 2, 2013, and Monday, June 3, 2013 of the conference. Over the course of two days, attendees have the opportunity to network and visit with exhibitors during 6.5 hours dedicated solely to exhibition time. Click here to read entire article.
Preview what you can Expect to see from our Exhibitors at Compounders on Capitol Hill
Learn more about Compounders on Capitol Hill exhibitors and what they will be showcasing at the meeting before you arrive in Arlington, Va! To see what their company offers and how you can work with them, click on IACP's YouTube image!
Click here to learn more about each exhibitor and their services and products.
Thank you to our CCH Exhibitors and Meeting Sponsors!
We would like to thank the following exhibitors for their commitment to Compounders on Capitol Hill: American College of Apothecaries (ACA); Analytical Research Laboratories (ARL); Associates of Cape Cod, Inc.; B&B Pharmaceuticals, Inc.; bioMérieux; Charles River Laboratory; Digi-Trax Corporation; DYNA Labs; Eagle Analytical Services; EMD Millipore; Exakt Technologies, Inc.; Fagron (formally Gallipot); Freedom Pharmaceuticals, Inc.; Humco Compounding; International Journal of Pharmaceutical Compounding (IJPC); International Medical Industries, Inc.; IsoTech Design; Letco Medical; Life File; Live Oak Bank; Mar Cor Purification; MEDISCA; PCAB; PCCA; Pharmacy Marketing Quarterly; RxCoop, LLC; RXinsider; Storey Marketing; Torpac Capsules; and ZRT Laboratory, LLC.
To learn more about the exhibitors and meeting sponsors, click here.
Reserve your hotel room online by clicking here.
Register to attend the conference before April 2, 2013 and take advantage of advance discount prices. To register for the conference or for more information, visit www.iacprx.org/cch.
Compounders on Capitol Hill
State-by-state Compounding Update
IACP's Compounders Stateside is a one-stop resource for state compounding updates and the latest happenings with the state Boards of Pharmacy. Please be sure to check this page periodically, as it will continue to be updated as situations evolve with each individual state. For example, check out the latest information from Florida. Click here to view Compounders Stateside which is prominently featured on IACP’s homepage.
IACP is your one-stop resource for all things compounding! CompounderCalendar provides a comprehensive listing of compounding events and continuing education programs.
Stay connected to IACP by joining our online communities!
Tell us how compounded pharmaceuticals have helped you, someone you know, or how you have helped someone as a practicing compounding pharmacist. Help us protect your continued access to pharmacy compounding!
Share the P3 community and the value and necessity of personalized prescriptions with your friends.